Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Croatian Cooperative Group For Clinical Trial Research In Oncology

Croatia Busiceva 5, 21000 Split, Croatia

About the sponsor

Research is centered on hormone receptor-positive, HER2-negative disease in men and postmenopausal women, with particular attention to PIK3CA-mutated cases that have progressed after prior endocrine therapy.

  • Hormone receptor-positive breast cancer
  • HER2-negative disease
  • PIK3CA mutation

The clinical focus includes treatment-resistant advanced breast cancer and the management of disease that remains dependent on endocrine pathways.

About Specializations

Croatian Cooperative Group For Clinical Trial Research In Oncology runs clinical trials in conditions such as Breast cancer metastatic, Hormone receptor positive HER2 negative breast cancer, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Breast cancer metastatic+1

Not yet recruiting
Registered drugNo placebo
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Croatian Cooperative Group For Clinical Trial Research In Oncology

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.